Novavax, Inc. Sustainability Profile
Novavax, Inc., a leading biotechnology company headquartered in the United States, focuses on the development of innovative vaccines to combat infectious diseases. Founded in 1987, Novavax has made significant strides in the vaccine industry, particularly with its proprietary nanoparticle technology, which enhances immune responses. The company is renowned for its COVID-19 vaccine candidate, NVX-CoV2373, which has demonstrated promising efficacy in clinical trials. Novavax's commitment to advancing vaccine development has positioned it as a key player in the global health landscape, particularly in the fight against emerging infectious diseases. With a strong emphasis on research and development, Novavax continues to expand its portfolio, aiming to address unmet medical needs worldwide.
DitchCarbon Score
How does Novavax, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novavax, Inc.'s score of 19 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novavax, Inc.'s reported carbon emissions
Novavax, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that Novavax may not have established formal commitments to reduce its carbon footprint or may not have publicly disclosed such information. In the context of the biopharmaceutical industry, many companies are increasingly focusing on sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Novavax's position relative to its peers in terms of climate commitments.
How Carbon Intensive is Novavax, Inc.'s Industry?
How Carbon Intensive is Novavax, Inc.'s Location?
Novavax, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novavax, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
